Type 2 Diabetes Mellitus: From Metabolic Dysfunction Syndrome to Precision Prevention and Targeted Therapy
Journal of Tropical Pharmacy and Chemistry · 31.07.2026 · 10 (2) · 97-106
DOI: 10.30872/jtpc.v10i2.439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Tropical Pharmacy and Chemistry, online erschienen am 31.07.2026. Verfasst von Putri Karenina Amalia Wulandari und 2 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) remains a prevalent metabolic disorder worldwide, continuously imposinga substantial clinical and socioeconomic burden. Traditionally viewed as a glucose-centered diseasecharacterized by hyperglycemia driven by insulin resistance and pancreatic beta-cell dysfunction, recentevidence clearly indicates that hyperglycemia is merely a downstream manifestation of broader metabolicabnormalities. Advances in molecular biology, immunometabolism, and systems biology have facilitated theemergence of Metabolic Dysfunction Syndrome (MDS) as a comprehensive framework for understandingT2DM pathogenesis. This review summarizes the interconnected roles of insulin resistance, adipose tissuedysfunction, ectopic lipid accumulation, chronic low-grade inflammation, oxidative stress, mitochondrialdysfunction, progressive beta-cell failure, and inter-organ crosstalk in disease progression. Furthermore, weextensively discuss the vital clinical implications of this paradigm shift, highlighting the critical importance ofearly risk stratification, prescreening, timely diagnosis, and personalized therapeutic algorithms extendingbeyond mere glycemic control. Emerging pharmacological therapies with cardiometabolic and renoprotectivebenefits, combined with holistic lifestyle interventions, firmly support a vital transition fromreactive glucose-lowering strategies to proactive disease-modifying approaches targeting underlyingmetabolic dysfunction. Ultimately, adopting the MDS framework provides a highly integrated understandingof T2DM, directly offering unprecedented opportunities for precision prevention, individualized treatment,and improved long-term clinical outcomes globally for all affected patients.
Zitieren
APA
Wulandari, P. K. A., Sylvana, D., & Suandy, S. (2026). Type 2 Diabetes Mellitus: From Metabolic Dysfunction Syndrome to Precision Prevention and Targeted Therapy. Journal of Tropical Pharmacy and Chemistry, 10(2), 97-106. https://doi.org/10.30872/jtpc.v10i2.439
Vancouver
Wulandari PKA, Sylvana D, Suandy S. Type 2 Diabetes Mellitus: From Metabolic Dysfunction Syndrome to Precision Prevention and Targeted Therapy. Journal of Tropical Pharmacy and Chemistry. 2026;10(2):97-106. doi:10.30872/jtpc.v10i2.439
BibTeX
@article{Wulandari2026,
author = {Wulandari, Putri Karenina Amalia and Sylvana, Dhiny and Suandy, Suandy},
title = {Type 2 Diabetes Mellitus: From Metabolic Dysfunction Syndrome to Precision Prevention and Targeted Therapy},
journal = {Journal of Tropical Pharmacy and Chemistry},
year = {2026},
volume = {10},
number = {2},
pages = {97--106},
doi = {10.30872/jtpc.v10i2.439}
}
EUVIMED